Home > Browse Reports > Medical Devices > Patient Monitoring Markets

Report Description

Patient Monitoring Markets
Publication Date: 01-DEC-08
Pages: 318
Study: TMRMPPMM
Format/Price: PDF document / $3,400.00
   


Description:



View Sample PDF


Patient monitoring is vital to care in operating rooms, emergency rooms, intensive care units and critical care units. It has proven invaluable for respiratory therapy, recovery rooms, outpatient care, transport, radiology, catheterization laboratories and gastroenterology departments, as well as for ambulatory, home and sleep screening applications. Patient monitoring can reduce the risk of infection and other complications, and it can assist in providing for patient comfort. Moreover, patient monitoring products measure, display and document physiological information obtained at regular intervals over time from sensors attached to the patient or other input devices. The qualifier "at regular intervals over time" is used to distinguish patient monitoring devices from diagnostic kits and devices, which are typically used once or a few times to diagnose a patient's condition and/or plan a course of therapy. Measured parameters include electrocardiogram (ECG), invasive and noninvasive blood pressure, pulse rate, pulse oximetry, body temperature, respiration rate, end-tidal CO2 and other specialized parameters. Products vary from specialized single-parameter instruments to monitors with the ability to measure multiple parameters and interface with other instruments. This TriMark Publications report assesses the patient monitoring device market drivers and bottlenecks from the perspective of medical and manufacturer communities; discusses the potential benefits of the patient monitoring device market for various sectors of the medical community; establishes the current total market size and future growth of the patient monitoring device market and analyzes the current size and growth of various segments; provides current and forecasted market shares by the company; provides strategic recommendations for near-term business opportunities and assesses current commercial uses of the patient monitoring market.





Table of Contents:

  1. 1. Introduction 11
  2. 1.1 Report Objectives 11
  3. 1.2 Scope of This Report 11
  4. 1.3 Methodology 12
  5. 1.4 Executive Summary 13
  6. 2. Top 30 Global Medical Device Companies, 2008 15
  7. 2.1 Johnson & Johnson 15
  8. 2.2 GE Healthcare 17
  9. 2.3 Siemens Healthcare 18
  10. 2.4 Medtronic 19
  11. 2.5 Cardinal Health 22
  12. 2.6 Baxter International 23
  13. 2.7 Philips Healthcare 24
  14. 2.8 Boston Scientific 25
  15. 2.9 Covidien 27
  16. 2.10 Becton Dickinson & Co. 28
  17. 2.11 Abbot Laboratories 30
  18. 2.12 Stryker 31
  19. 2.13 B. Braun 32
  20. 2.14 3M Healthcare 33
  21. 2.15 Zimmer Holdings 34
  22. 2.16 St. Jude Medical 35
  23. 2.17 Hospira 36
  24. 2.18 Smith & Nephew 36
  25. 2.19 Donaher 38
  26. 2.20 Synthes 38
  27. 2.21 Beckman Coulter 39
  28. 2.22 Olympus Medical Systems 40
  29. 2.23 Fresenius Medical Care 40
  30. 2.24 Alcon 41
  31. 2.25 Terumo Medical 42
  32. 2.26 C.R. Bard 43
  33. 2.27 Biomet 44
  34. 2.28 Dentsply International 45
  35. 2.29 Dräger Medical AG & Co. 46
  36. 2.30 Varian 47
  37. 3. Medical Design Excellence Awards (MDEA), 2008 49
  38. 3.1 MDEA Official Rules, 2009 49
  39. 3.2 MDEA Award Winners and Patient Monitoring Products, 2008 50
  40. 3.2.1 NetGuard Wireless Electrocardiograph System 50
  41. 3.2.2 Genesis DM Telehealth Device 50
  42. 3.2.3 E4D Dentist System 50
  43. 3.2.4 Tono-Pen Avia Applanation Tonometer 51
  44. 3.2.5 Healthy Living ThinLine Deluxe Flat Screen Blood Pressure Monitor, Model BSD-3007 51
  45. 3.2.6 Acuson P10 Handheld Diagnostic Ultrasound Unit 51
  46. 3.2.7 MicroDose Mammography System 52
  47. 3.2.8 Nuance Full-field Digital Mammography Unit 52
  48. 3.2.9 xCAT Computed Tomography Scanner 52
  49. 3.2.10 XDS Extravasation Detector 53
  50. 3.3 MDEA Award Winners and Patient Monitoring Products, 2007 and 2006 53
  51. 3.3.1 Mobile Clinical Assistant 53
  52. 3.3.2 Halo 360 Esophageal Tissue Ablation System 53
  53. 3.3.3 OmniPod Insulin Management System 54
  54. 3.3.4 Rad-57 Portable Pulse CO-Oximeter 54
  55. 4. Global Medical Device Market Outperforms Drug Market Growth 55
  56. 4.1 Market Shares of Medical Devices 56
  57. 5. Patient Monitors 57
  58. 5.1 Patient Monitoring Markets 58
  59. 5.2 Competition from Asian Manufacturers 60
  60. 5.3 Opportunities for Midrange Monitors 60
  61. 5.4 Size of Patient Monitoring Market 62
  62. 5.5 Drivers and Restraints of Patient Marketing 62
  63. 5.6 Global Market for Patient Monitoring Systems 63
  64. 5.7 Industry Trends 64
  65. 5.8 Price Pressures 64
  66. 5.9 Ease of Use of Patient Monitors 65
  67. 5.10 Reducing Medical Errors 65
  68. 5.11 Clinical Solutions 65
  69. 5.12 Data Interfaces and Interoperability 66
  70. 5.13 Aggressive Marketing Strategies and End-User Benefits to Spur Growth 67
  71. 5.14 Newer Markets, Higher Replacement Rates Provide Impetus 68
  72. 5.15 Stringent Regulations to Offset Inconsistent Reimbursement Policies 68
  73. 5.16 Advanced Systems Initiate Market Expansion and Combat Staff Shortages 68
  74. 5.17 Aging Population Provides Sustained Need for Equipment While Specialty and Alternate Care Centers Offer New Markets 68
  75. 5.18 Wireless Data Transfer 69
  76. 5.19 Integration of Data/Information with Patient Monitors Gaining Priority 69
  77. 5.20 Hospital Opportunities 69
  78. 5.21 Supplier Consolidation 69
  79. 6. Multiparameter Patient Monitors 71
  80. 6.1. Multiparameter Patient Monitoring Systems 71
  81. 6.1.1 Future of Multiparameter Patient Monitoring Systems 73
  82. 6.1.2 Multiparameter Patient Monitors-Product Introduction 73
  83. 6.1.3 Product Trends and Technologies-Multiparameter Patient Monitors 74
  84. 6.1.4 Advanced Monitoring Parameters in Multiparameter Patient Monitors 74
  85. 6.1.5 Anesthetic Assessment Using Multiparameter Brain Monitors 74
  86. 6.2 Leading Players in Multiparameter Patient Monitoring Manufacture 75
  87. 6.2.1 Analogic Corporation-Company Overview 76
  88. 6.2.2 Product Offering 76
  89. 6.2.3 Smiths Medical-Company Overview 78
  90. 6.2.3.1 Product Offering 78
  91. 6.2.4 CAS Medical Systems, Inc.-Company Overview 82
  92. 6.2.4.1 Product Offering 83
  93. 6.2.5 Omron Corporation-Company Overview 84
  94. 6.2.5.1 Product Offering 85
  95. 6.2.6 Opto Circuits (India) Ltd.-Company Overview 88
  96. 6.2.6.1 Opto Circuits Subsidiaries 89
  97. 6.2.6.2 Product Offering 90
  98. 6.2.7 Dräger Medical-Company Overview 91
  99. 6.2.7.1 Product Offering 91
  100. 6.2.8 Fukuda Denshi Group-Company Overview 100
  101. 6.2.8.1 Product Offering 101
  102. 6.2.9 GE Healthcare-Company Overview 103
  103. 6.2.9.1 Product Offering 103
  104. 6.2.10 Masimo-Company Overview 107
  105. 6.2.10.1 Product Offering 107
  106. 6.2.11 Mindray-Company Overview 109
  107. 6.2.11.1 Product Offering 109
  108. 6.2.12 Nihon Kohden-Company Overview 114
  109. 6.2.12.1 Product Offering 115
  110. 6.2.13 Philips Healthcare-Company Overview 121
  111. 6.2.13.1 Product Offering 123
  112. 6.2.14 Schiller A.G.-Company Overview 126
  113. 6.2.14.1 Product Offering 126
  114. 6.2.15 Siemens-Company Overview 127
  115. 6.2.15.1 Product Offering 128
  116. 6.2.16 Spacelabs Healthcare-Company Overview 130
  117. 6.2.16.1 Product Offering 131
  118. 6.2.17 Welch Allyn-Company Overview 136
  119. 6.2.17.1 Product Offering 136
  120. 7. Pulse Oximetry 140
  121. 7.1 Principles of Pulse Oximetry Technology 141
  122. 7.2 Clinical Use 142
  123. 7.3 Limitations of Conventional Pulse Oximetry 143
  124. 7.4 Pulse Oximetry Market Drivers and Restraints 144
  125. 7.5 Market Opportunities 144
  126. 7.5.1 Expansion to Non-Critical Care Settings 144
  127. 7.5.2 Carboxyhemoglobin Detection 144
  128. 7.5.3 Methemoglobin Detection 145
  129. 7.5.4 Plethysmograph Variability Index (PVI) 145
  130. 7.5.5 Total Hemoglobin (SpHb) 145
  131. 7.5.6 Signal Processing and Innovative Sensor Technology 146
  132. 7.5.7 Cerebral Oximetry 146
  133. 7.6 Global Market for Pulse Oximeters 147
  134. 7.6.1 Dominant Players in Pulse Oximeter Market 148
  135. 7.6.2 Benefits of Products and Technology 149
  136. 7.6.3 Business Strategies for the Pulse Oximetry Market 149
  137. 7.7 Pulse Oximetry Products 150
  138. 7.7.1 Circuit Boards 150
  139. 7.7.2 Sensors 151
  140. 7.7.3 Remote-Alarm and Monitoring Solutions 151
  141. 7.8 Product Offering-Pulse Oximeters/Monitors 152
  142. 7.9 Drivers and Restraints of Oximeter Markets 156
  143. 7.10 Demand for Pulse Oximeters in Hospitals and Alternate Care Market Generates Growth 156
  144. 8. Electrocardiogram Services 157
  145. 8.1 Market 157
  146. 8.2 Competition 158
  147. 8.3 Opportunites and Challenges 158
  148. 8.4 Cardiac Monitoring Products 159
  149. 8.4.1 Resting ECG Systems 159
  150. 8.4.2 Cardiac Stress Testing Systems 160
  151. 8.4.3 Holter Monitoring Systems 160
  152. 8.4.4 Cardiac Rehabilitation Telemetry Systems 161
  153. 8.4.5 Cardiology Data Management Systems 161
  154. 8.4.6 Advantages of Cardiac Monitoring Products 162
  155. 8.4.7 Product Suppliers 163
  156. 8.4.7.1 Monebo 163
  157. 8.4.7.2 CompuMed, Inc. 163
  158. 8.4.7.3 Cardiac Science Corp. 164
  159. 8.4.7.4 Royal Philips Electronics 164
  160. 8.4.7.5 Datascope (Mindray) 164
  161. 8.4.7.6 Fakuda Denshi 165
  162. 8.4.7.7 Scott Care 165
  163. 8.4.7.8 Dräger 165
  164. 9. Capnography 166
  165. 9.1 Use in Hospitals 167
  166. 9.2 Capnography Market Size 168
  167. 9.3 Commercially-Available Devices 168
  168. 10. Maternal Fetal Monitors 170
  169. 11. Blood Pressure Monitors 175
  170. 11.1 Market Overview 175
  171. 11.2 Market Sectors 175
  172. 11.3 Blood Pressure Monitoring Products 177
  173. 11.3.1 Non-Invasive Blood Pressure Cuffs 177
  174. 11.3.2 Invasive Arterial Catheters 180
  175. 12. Anesthesia Monitoring 182
  176. 12.1 Anesthesia Monitoring Market Size 182
  177. 12.2 Anesthesia Monitoring Competition 182
  178. 12.3 Anesthesia Monitoring Products 182
  179. 12.3.1 Neurological Monitors 182
  180. 12.4 Market Size 184
  181. 12.5 Neurological Intraoperative Monitoring 185
  182. 12.5.1 Neurological Monitoring in Intensive Care 186
  183. 13. Trends in Mobile Medical Monitor Device Design and Manufacturing 188
  184. 13.1 Pervasive Patient Monitoring 189
  185. 14. Home Healthcare 190
  186. 14.1 Home Healthcare Market 191
  187. 14.2 U.S. Home Healthcare Scenario 192
  188. 14.3 Homecare Providers 192
  189. 14.4 Medicare Certified Agencies 192
  190. 14.5 Medicare-Certified Hospices 193
  191. 14.6 Non-Medicare-Certified Agencies 193
  192. 14.7 Home Care Expenditures and Utilization 193
  193. 14.8 Medicare Home Health 194
  194. 14.9 Managed Care 195
  195. 14.10 Homecare Recipients 195
  196. 14.11 Caregivers 196
  197. 14.12 Formal Caregivers 196
  198. 14.13 Future of Home Healthcare in the U.S. 197
  199. 14.14 Selected List of Home Healthcare Products 198
  200. 14.15 Leading U.S. Home Healthcare Providers 203
  201. 14.16 Company Overview of Two of the 50 Home Healthcare Providers 205
  202. 15. Telemedicine and Telehealth 207
  203. 15.1 What Are Telemedicine and Telehealth? 207
  204. 15.2 Why Telemedicine? 207
  205. 15.3 Defining Telemedicine 207
  206. 15.4 Types of Telemedicine Services 208
  207. 15.5 Delivery Mechanisms 208
  208. 15.6 The U.S. Telehealth Survey 209
  209. 15.7 Telemonitoring 209
  210. 15.8 Market Trends-Telemonitoring 210
  211. 15.9 Telehealthcare in Europe 210
  212. 15.9.1 Scottish Center for Telehealth 211
  213. 15.10 Telehealth and Telehomecare Bound to Get Big in Japan 211
  214. 15.11 MedStar System 212
  215. 15.12 MedApps D-PAL Remote Patient Monitoring System for Diabetes 213
  216. 15.13 Telehealth and Troubled Pregnancies 213
  217. 15.14 Tele-Cardiology in the Forefront of New Telehealth Services 214
  218. 15.15 Economical Benefits of Tele-Cardiology 214
  219. 15.16 ECG Telemetry Devices Market 215
  220. 15.17 Remote Patient Monitoring In-Home Devices from Philips 216
  221. 15.18 Glucose Monitoring Made Easy by Gluco Tel System 217
  222. 15.19 Aerotel Medical Systems, Ltd.-Company Overview 218
  223. 15.19.1 Heartline ECG Monitoring 218
  224. 15.20 Home Telehealth, Ltd. U.K 223
  225. 16. U.S. Market for Medical Devices 225
  226. 16.1 U.S. Export of Medical Devices to Japan 225
  227. 16.2 U.S. Exports and Imports of Medical Devices 226
  228. 16.3 Facts and Figures of U.S Medical Device Market 227
  229. 16.4 U.S. Patient Monitoring Market 227
  230. 16.5 Trends Affecting the U.S. Patient Monitoring Equipment Industry 228
  231. 16.6 U.S. Market Drivers 228
  232. 16.7 Aging Patient Population 228
  233. 16.8 Hunger and Obesity 229
  234. 16.9 Nursing Shortage 230
  235. 16.10 Shifts from Hospital to Outpatient Care 230
  236. 16.11 U.S. Market Restraints 230
  237. 16.12 Government Reguation of Medical Devices 232
  238. 16.12.1 FDA's Premarket Clearance and Approval Requirements 232
  239. 16.12.2 510(k) Clearance Process 232
  240. 16.12.3 Premarket Approval Process 233
  241. 16.12.4 Clinical Trials 233
  242. 16.12.5 Continuing FDA Patient Monitoring Product Regulation 233
  243. 16.12.6 International Regulations 234
  244. 17. European Patient Monitoring Market 235
  245. 17.1 E.U. Production of Medical Devices 236
  246. 17.2 E.U. Medical Device Consumption 237
  247. 17.3 E.U. Exports and Imports 237
  248. 17.4 Main Medical Device Markets in Europe 238
  249. 17.4.1 France 238
  250. 17.4.2 United Kingdom 238
  251. 17.4.3 Spain 238
  252. 17.4.4 Germany 238
  253. 17.4.5 Italy 239
  254. 17.4.6 Switzerland 239
  255. 17.4.7 Netherlands 239
  256. 17.4.8 Sweden 239
  257. 17.4.9 Czech Republic 239
  258. 17.4.10 Greece 239
  259. 17.5 Medical Device Industry in Turkey 240
  260. 17.5.1 Turkey-Exports 240
  261. 17.6 European Trends and Drivers 241
  262. 18. Asia/Pacific Patient Monitoring Market 242
  263. 18.1 China 242
  264. 18.1.1 Facts and Figures of Chinese Medical Device Market 242
  265. 18.2 Japan 243
  266. 18.2.1 Japan's Aging Population and the Demand for Foreign Medical Devices 243
  267. 18.2.2 Japanese Medical Device Market 244
  268. 18.3 India 245
  269. 18.3.1 India-Imported Medical Devices 246
  270. 18.3.2 Global Medical Toolmakers Throng India 247
  271. 18.4 Indian Healthcare 2008 at a Glance and the Opportunities for Foreign Investments 247
  272. 18.4.1 Indian Healthcare, a $34.2 Billion Market 247
  273. 18.4.2 Indian Healthcare Market-Growth Perspective 247
  274. 18.4.3 Medical Infrastructure-Current State 248
  275. 18.4.4 Medical Education and Manpower-India's Advantage 248
  276. 18.4.5 Budget 2007-2008 and Indian Healthcare Perspective 249
  277. 18.4.6 Healthcare Budget 2007-2008 Highlights 249
  278. 18.4.7 Key Trends and Drivers-Shift to Lifestyle Related Diseases 249
  279. 18.4.8 Growing Middle Class and Patient Preferences 250
  280. 18.4.9 JCI Accreditated Organizations in India 250
  281. 18.4.10 Healthcare Cities-The Evolving Concept of Healthcare in India 250
  282. 18.4.11 Healthcare Insurance-Current and Future Scenario 251
  283. 18.4.12 Impelling Technology 252
  284. 18.4.13 Reverse in Brain Drain 252
  285. 18.4.14 Funding by Private Equity 252
  286. 18.4.15 Select Players in India-Apollo Hospitals Enterprise, Ltd. 253
  287. 18.4.16 Fortis Healthcare 253
  288. 18.4.17 Wockhardt Hospitals 253
  289. 18.4.18 Manipal Health Systems 253
  290. 18.4.19 Narayana Hrudayalaya 254
  291. 18.4.20 Max Healthcare 254
  292. 18.4.21 Columbia Asia 254
  293. 18.4.22 Global Hospitals 254
  294. 18.4.23 Artemis Health Institute 254
  295. 18.4.24 New Entrants-Naresh Trehan's MediCity 254
  296. 18.4.25 Aditya Birla Memorial Hospital 254
  297. 18.4.26 Reliance ADAG Healthcare 255
  298. 18.4.27 Foreign Players 255
  299. 18.4.28 Opportunities in Medical Value Travel 255
  300. 18.4.29 Medical Equipment Manufacturing and Leasing in India 255
  301. 18.4.30 Healthcare Outsourcing 256
  302. 18.5 Korea 256
  303. 18.6 Singapore 257
  304. 18.6.1 Singapore-Market Review 257
  305. 18.6.2 Singapore-Import Market 257
  306. 18.7 Malaysia 257
  307. 18.7.1 Malaysia Serving the Asia and World Healthcare Market 259
  308. 18.8 Patient Monitoring Market Presents Opportunities in South Africa 260
  309. 18.9 Vietnam 260
  310. 18.9.1 Vietnam-Market Overview 260
  311. 18.9.2 Vietnam-Market Profile 260
  312. 18.9.3 Vietnam-Import Market 260
  313. 18.9.4 Vietnam-Domestic Production 261
  314. 18.9.5 Vietnam-Third Country Imports 261
  315. 18.9.6 Vietnam-Market Position in the U.S. 261
  316. 18.10 Russia 262
  317. 18.11 Australia 262
  318. 18.12 Rest of World Patient Monitoring Market 262
  319. 18.13 Argentina Medical Device Market 262
  320. 18.13.1 Argentina-Medical Instruments and Accessories Market 263
  321. Appendix 1: Conditions Affecting U.S. Trade in Medical Devices 265
  322. Appendix 2: Healthcare in the U.S. 270
  323. Appendix 3: Business Developments in Patient Monitoring Sector 278
  324. Appendix 4: U.S. Medicare-A Snapshot 282
  325. Appendix 5: U.S. Medicaid at a Glance 293
  326. Appendix 6: Alternate Financial Solution for Medical Technology Acquisition 296
  327. Appendix 7: Registering Medical Products in China 300
  328. Appendix 8: Registering Medical Products in India 302
  329. Appendix 9: Registering Medical Products in Japan 304
  330. Appendix 10: Registering Medical Products in Russia 306
  331. Appendix 11: Registering Medical Products in Mexico 308
  332. Appendix 12: Group Purchasing Organizations 312
  333. Appendix 13: Company Directory 313
  334. Appendix 14: Abbreviations 317
  335. INDEX OF TABLES
  336. Table 2.1: Johnson & Johnson Snapshot, 2007-2008 15
  337. Table 2.2: GE Healthcare Snapshot, 2007-2008 17
  338. Table 2.3: Siemens Healthcare Snapshot, 2007-2008 18
  339. Table 2.4: Medtronic Snapshot, 2007-2008 19
  340. Table 2.5: Cardinal Health Snapshot, 2007-2008 22
  341. Table 2.6: Baxter International Snapshot, 2007-2008 23
  342. Table 2.7: Philips Healthcare Snapshot, 2007-2008 24
  343. Table 2.8: Boston Scientific Snapshot, 2007-2008 25
  344. Table 2.9: Boston Scientific Sales by Product Category, 2003-2007 25
  345. Table 2.10: Covidien Snapshot, 2007-2008 27
  346. Table 2.11: Becton Dickinson & Co. Snapshot, 2007-2008 28
  347. Table 2.12: Abbot Laboratories Snapshot, 2007-2008 30
  348. Table 2.13: Stryker Snapshot, 2007-2008 31
  349. Table 2.14: B. Braun Snapshot, 2007-2008 32
  350. Table 2.15: 3M Healthcare Snapshot, 2007-2008 33
  351. Table 2.16: Zimmer Holdings Snapshot, 2007-2008 34
  352. Table 2.17: St. Jude Medical Snapshot, 2007-2008 35
  353. Table 2.18: Hospira Snapshot, 2007-2008 36
  354. Table 2.19: Smith & Nephew Snapshot, 2007-2008 36
  355. Table 2.20: Donaher Snapshot, 2007-2008 38
  356. Table 2.21: Synthes Snapshot, 2007-2008 38
  357. Table 2.22: Beckman Coulter Snapshot, 2007-2008 39
  358. Table 2.23: Olympus Medical System Snapshot, 2007-2008 40
  359. Table 2.24: Fresenius Medical Care Snapshot, 2007-2008 40
  360. Table 2.25: Alcon Snapshot, 2007-2008 41
  361. Table 2.26: Terumo Medical Snapshot, 2007-2008 42
  362. Table 2.27: C.R. Bard Snapshot, 2007-2008 43
  363. Table 2.28: Biomet Snapshot, 2007-2008 44
  364. Table 2.29: Dentsply International Snapshot, 2007-2008 45
  365. Table 2.30: Dräger Medical Snapshot, 2007-2008 46
  366. Table 2.31: Varian Snapshot, 2007-2008 47
  367. Table 4.1: Leading Medical Device Companies, 2007 55
  368. Table 4.2: Top 30 Companies of Medical Devices and Their Sales, 2007 56
  369. Table 5.1: Overall Global Patient Monitoring Sales and Projections, 2006-2013 57
  370. Table 5.2: U.S. Patient Monitoring Market and Projections, 2006-2013 57
  371. Table 5.3: U.S. Patient Monitoring Home Care Market and Projections, 2006-2013 57
  372. Table 5.4: U.S. Patient Monitoring Handheld and Wearable Market and Projections, 2006-2013 58
  373. Table 5.5: Technology Synopsis for Each Market Segment in the U.S. 58
  374. Table 5.6: Estimated Market Share Analysis for Top Suppliers-U.S. Patient Monitoring Market Segments 59
  375. Table 5.7: Average Equipment Selling Price for Each Market Segment in the U.S. 59
  376. Table 5.8: Commonly-Monitored Parameters in the U.S. 59
  377. Table 5.9: Summary of Market Projections 62
  378. Table 5.10: Drivers of Patient Monitoring Markets 62
  379. Table 5.11: Restraints of Patient Monitoring Markets 63
  380. Table 5.12: Recent Sector M&A Activity 70
  381. Table 5.13: Mergers and Acquisitions, 1997-2008 70
  382. Table 6.1: Websites for Other Manufacturers 75
  383. Table 6.2: Nihon Kohden Sales by Product Category 121
  384. Table 7.1: Growth Drivers in the U.S. Pulse Oximetry Sensor Market 144
  385. Table 7.2: Pulse Oximetry Monitoring Equipment Market: Major Market Participants 149
  386. Table 7.3: Pulse Oximetry Components and Markets for Distribution 150
  387. Table 7.4: Popular Brands of Oximeters 155
  388. Table 7.5: Principal Competitive Factors for Pulse Oximetry Products 155
  389. Table 7.6: Drivers of Pulse Oximetry Markets 156
  390. Table 7.7: Restraints of Pulse Oximetry Markets 156
  391. Table 8.1: Worldwide Cardiac Equipment Monitoring Market: Revenue and Forecasts, 2005-2013 157
  392. Table 8.2: U.S. Cardiac Equipment Monitoring Market: Revenue and Forecasts, 2005-2013 158
  393. Table 8.3: Challenges in Cardiac Monitoring 158
  394. Table 8.4: Leading Competitors for Cardiac Moniitoring Systems 163
  395. Table 9.1: U.S. Capnography Monitoring Equipment Market, 2006-2013 168
  396. Table 10.1: Key Companies in Fetal Monitors 170
  397. Table 10.2: Specific Categories of Fetal Monitors 171
  398. Table 10.3: Available Equipment for Fetal Monitoring 171
  399. Table 10.4: Recent Fetal Monitor Sector M&A Activity 171
  400. Table 11.1: Key Companies in Blood Pressure Monitors 176
  401. Table 11.2: Available Equipment for Blood Pressure Monitoring 176
  402. Table 11.3: Recent Blood Pressure Sector M&A Activity 177
  403. Table 12.1: U.S. Anesthesia Monitoring Equipment Market, 2006-2013 182
  404. Table 12.2: Worldwide Neurological Equipment Monitoring Market: Revenue and Forecasts, 2005-2013 185
  405. Table 12.3: U.S. Neurological Equipment Monitoring Market: Revenue and Forecasts, 2005-2013 185
  406. Table 14.1: Number of Medicare-Certified Home Care Agencies, 1967-2007 192
  407. Table 14.2: U.S. Number of Home Healthcare Workers and Medicare-Certified Agencies, 2007 196
  408. Table 14.3: Comparison of Hospital, SNF and Home Health Medicare Charges, 2005-2007 197
  409. Table 14.4: U.S. Annual Expenditure on Home Healthcare Products, 2006 197
  410. Table 14.5: U.S. Medicaid Spending on Home Healthcare and Personal Care, 2006 203
  411. Table 15.1: Telehealth Benefits 209
  412. Table 15.2: Telemonitoring Market Highlights 210
  413. Table 15.3: Benefits of HeartView Tele-Cardiology Service 214
  414. Table 15.4: Drivers for Remote Patient Monitoring 215
  415. Table 15.5: Barriers to Remote Patient Monitoring 215
  416. Table 15.6: Forecast for U.S. Remote Patient Monitoring Devices, 2003-2010 216
  417. Table 15.7: Leading Market Participants in Telemetry Devices 216
  418. Table 16.1: Japanese Medical Devices Market Size, 2005-2007 226
  419. Table 16.2: U.S. Market for Medical Devices, 2002-2007 227
  420. Table 16.3: Senior Citizen Use of Medical Services in the U.S. 229
  421. Table 16.4: Impact of Aging Population on Patient Monitoring Demand in the U.S. 229
  422. Table 16.5: Nursing Staffing Levels Contribute to Incidents 230
  423. Table 16.6: The U.S. Medical Equipment Market Value, 2004-2007 231
  424. Table 16.7: Top U.S. Export Markets of Medical Devices, 2006 231
  425. Table 17.1: Turkish Medical Devices Export, 2002-2007 241
  426. Table 17.2: Turkish Medical Devices Export by Product Groups, 2003-2007 241
  427. Table 18.1: Japanese Medical Device Market, 2005-2007 243
  428. Table 18.2: Percentage of Elderly Population in Developed Countries, 1950, 1985, 2000 and 2020 243
  429. Table 18.3: Presence of Foreign Companies in Japanese Market 244
  430. Table 18.4: Leading Manufacturers of Medical Devices in Japan 245
  431. Table 18.5: Upcoming Healthcare Cities 251
  432. Table 18.6: Foreign Companies Entering India 256
  433. Table 18.7: Foreign Companies with a Presence in Malaysia 259
  434. Table 18.8: Global Medical Equipment Market, 2008-2011 259
  435. Table 18.9: Summary of Medical Device Market in Malaysia, 2008 259
  436. Table 18.10: Argentina-Medical Device Industry Market Size, 2004-2006 263
  437. Table 18.11: Argentina-Medical Instruments and Accessories Market, 2005-2007 264
  438. Table App. 1.1: Summary of the U.S., E.U. and Japanese Medical Device Markets 267
  439. Table App. 2.1: Health Expenditures for Selected Type of Services, 2000, 2005, 2010 and 2015 272
  440. Table App. 2.2: U.S. Healthcare Industry Overview 273
  441. Table App. 2.3: U.S. Population without Health Insurance, 2007 274
  442. Table App. 3.1: Important Business Developments in the Patient Monitoring Sector 278
  443. Table App. 4.1: General Medicare-Statistics 292
  444. Table App. 6.1: Financial Services Offered by Medical Devices and Diagnostics Companies 299
  445. Table App. 12.1: Top Ten GPOs by Number of Hospital Members (Psychiatric and Rehabilitation Hospitals Included) by Total Number of Hospital Members 312
  446. INDEX OF FIGURES
  447. Figure 2.1: Johnson & Johnson Sales by Segment, 2007 16
  448. Figure 2.2: GE Healthcare Profit, 2006 17
  449. Figure 2.3: Siemens Healthcare Revenue Trend 18
  450. Figure 2.4: Medtronic Revenue by Segment, 2007 19
  451. Figure 2.5: Medtronic Revenue by Geography, 2007 20
  452. Figure 2.6: Medtronic Revenue and Operating Income, 2005-2007 20
  453. Figure 2.7: Medtronic Market Share, 2007 21
  454. Figure 2.8: Baxter International Revenue by Segment, 2006-2007 23
  455. Figure 2.9: Boston Scientific Investment in Research and Development, 2007 26
  456. Figure 2.10: Boston Scientific Sales by Geographic Segment, 2007 26
  457. Figure 2.11: Covidien FY 2005-2007 27
  458. Figure 2.12: Becton Dickinson Revenue by Segment, 2007 28
  459. Figure 2.13: Becton Dickinson Revenue and Operating Income, 2005-2007 29
  460. Figure 2.14: Becton Dickinson Revenue by Geography, 2007 29
  461. Figure 2.15: Abbot Laboratories Medical Devices Sales, 2007 30
  462. Figure 2.16: Abbot Sales by Business Group, 2007 31
  463. Figure 2.17: Abbot Sales by Geography, 2007 31
  464. Figure 2.18: Zimmer Revenue by Geography, 2006 34
  465. Figure 2.19: St. Jude Medical Revenue by Segment 35
  466. Figure 2.20: C.R. Bard Revenue by Segment, 2006-2007 43
  467. Figure 2.21: Biomet Sales, 2006-2007 45
  468. Figure 2.22: Dentsply International Revenue by Segment, 2004-2006 46
  469. Figure 2.23: Varian Revenue and Net Income, 2003-2007 47
  470. Figure 5.1: Worldwide Market Segmentation-High-, Mid- and Low-End Products 60
  471. Figure 5.2: Total Worldwide Patient Monitoring Market by Segment 61
  472. Figure 5.3: Worldwide Markets for Patient Monitors, Clinical Measurements, Clinical Information Systems and Networking 61
  473. Figure 5.4: Only 28% of U.S. Primary Care Doctors Use Electronic Medical Patient Records, 2006 67
  474. Figure 6.1: Block Diagram of a Multiparameter Patient Monitor 72
  475. Figure 6.2: Smiths Group Market Analysis by Destination 82
  476. Figure 6.3: Philips Is the World Leader in Patient Monitoring Market, 2000-2007 122
  477. Figure 7.1: Light Absorption by Pulse Oximeters in the Finger 141
  478. Figure 7.2: Block Diagram-Pulse Oximeter 141
  479. Figure 7.3: U.S. Pulse Oximetry Market Share by Company 148
  480. Figure 14.1: Global Home Healthcare Market, 2007 ($140 Billion plus) 191
  481. Figure 14.2: U.S. Personal Healthcare Expenditures, 2006 193
  482. Figure 14.3: U.S. Sources of Payment for Home Health, 2006 194
  483. Figure 14.4: U.S. Percent Medicare Payments by Benefit, 2000-2007 195
  484. Figure 14.5: U.S. Home Healthcare Services, Total Employment, 1996-2007 196
  485. Figure 15.1: The MedStar System 212
  486. Figure 16.1: U.S. Export of Medical Devices to Japan, 2007 225
  487. Figure 17.1: Health Spending on Medical Technology, 2007 235
  488. Figure 17.2: European Medical Technology Market by Country 235
  489. Figure 17.3: Projected Composition of E.U.'s Population by Age 237
  490. Figure 18.1: Composition of Japan's Population by Age, 1950-2050 243
  491. Figure 18.2: Growth Forecast for Medical Device Market in India 246
  492. Figure 18.3: Segmentation of Indian Medical Device Market 247
  493. Figure 18.4: Indian Healthcare Market Size 248
  494. Figure 18.5: Indian Healthcare Infrastructure 248
  495. Figure 18.6: Hospitalization Cases, 2007 250
  496. Figure 18.7: Insured Patients as a Percentage of Total Patients 251
  497. Figure 18.8: Health Insurance Revenue as a Percentage of Total Healthcare Revenue 252
  498. Figure 18.9: Medical Equipments-Market Distribution 255
  499. Figure 18.10: Outsourcing Scenario 2003-2004 and 2007-2008 256
  500. Figure 18.11: Argentina-Laboratory Analytical Instruments Market Share, 2006 263
  501. Figure 18.12: Argentina-Medical Instruments and Accessories Market, 2006 264
  502. Figure App. 1.1: Global Production in the Medical Device Industry, 2005 268
  503. Figure App. 1.2: Consumption of Medical Devices, 2005 268
  504. Figure App. 1.3: Global Trade in Medical Devices by Major Traders, 2005 268
  505. Figure App. 1.4: Share of the U.S. Shipments by Major Segments, 2005 269
  506. Figure App. 1.5: Bioengineering Grant Awards from National Institutes for Health (NIH) for Various Diseases 269
  507. Figure App. 2.1: Dimensions of a High Performance Health System 270
  508. Figure App. 2.2: Total Spending on Healthcare in the U.S., 1960-2007 271
  509. Figure App. 2.3: International Per Capita Healthcare Spending by Country, 2006 272
  510. Figure App. 2.4: Number Uninsured and Uninsured Rate in the U.S., 1987-2006 274
  511. Figure App. 2.5: Obese Adults in the U.S., 2006 275
  512. Figure App. 2.6: Prevalence of Obesity by Age, Race and Sex, U.S., 2006 275
  513. Figure App. 2.7: Age Adjusted Prevalence of Hypertension in U.S. Men and Women, 2006 276
  514. Figure App. 2.8: Age Adjusted Prevalence of Hypertension in the U.S., 2006 276
  515. Figure App. 4.1: Total U.S. Medicare Population, 2005 282
  516. Figure App. 4.2: Medicare Pays Nearly Half of the Beneficiaries 283
  517. Figure App. 4.3: Net Federal Cost of Medicare Prescription Drug Benefit 290
  518. Figure App. 5.1: Medicaid in the Health System, 2005 293
  519. Figure App. 5.2: Medical Expenditure by Service, 2005 294
  520. Figure App. 5.3: Medicaid Enrollees and Expenditures by Enrollment Group, 2003 295
  521. Figure App. 6.1: Factors to Be Taken into Consideration before Deciding on an Option 297
  522. Figure App. 11.1: Brazilian Commercial Balance, 1950-2005 308
Registration
Browse Reports
Search TriMark
Reading Room
My Account
View Cart
Home  |  Reports  |  Database Tables  |  Conferences  |  Contact Us  
     © 2008 TriMark Publications, LLC. All rights reserved.